The nurse is teaching her patient about possible teratogen exposure during pregnancy.

She correctly explains to her patient that teratogens are harmful agents that can cause fetal malformations.

She also correctly explains that.

Select all that apply.

Choice A rationale

Tampon use is a common and acceptable method for managing menstrual flow. It involves inserting a cylindrical absorbent material into the vagina to absorb menstrual blood. Scientifically, tampons function by capillary action, wicking fluid away from the vaginal canal. There are no inherent risks or abnormalities associated with tampon use itself that would necessitate further immediate inquiry without other concerning symptoms.

Choice B rationale

A menstrual cycle length varying from 26 to 29 days falls within the normal physiological range. A typical menstrual cycle can range from 21 to 35 days, with an average of 28 days. This variability is often influenced by hormonal fluctuations, particularly estrogen and progesterone, which regulate the follicular and luteal phases of the cycle.

Choice C rationale

Menorrhagia, or abnormally heavy menstrual bleeding, is defined as soaking through a pad or tampon in one hour or less for several consecutive hours. This can indicate an underlying gynecological issue, such as uterine fibroids, polyps, adenomyosis, or hormonal imbalances. Excessive blood loss also risks iron-deficiency anemia due to depletion of iron stores essential for hemoglobin synthesis.

Choice D rationale

A menstrual flow lasting 5-6 days is considered within the normal physiological range. The typical duration of menstrual bleeding is between 2 and 7 days. This duration is determined by the endometrial shedding process, which is initiated by the decline in progesterone levels at the end of the luteal phase of the menstrual cycle.

Choice A rationale

Oral contraceptive pills (OCPs) can be effective in managing primary dysmenorrhea by suppressing ovulation and reducing prostaglandin production, which lessens uterine contractions. However, they are not typically the *optimal initial pharmacologic therapy* for acute pain relief, but rather a long-term management strategy for persistent or severe symptoms.

Choice B rationale

Aspirin, a nonsteroidal anti-inflammatory drug (NSAID), inhibits prostaglandin synthesis and can provide some pain relief for dysmenorrhea. However, its anti-inflammatory effects are generally weaker compared to other NSAIDs, and it carries a higher risk of gastrointestinal side effects and Reye's syndrome in children, making it less optimal than other NSAIDs.

Choice C rationale

Acetaminophen is an analgesic that primarily works by inhibiting prostaglandin synthesis in the central nervous system, providing pain relief and fever reduction. While it can alleviate mild pain, it lacks the peripheral anti-inflammatory properties of NSAIDs, which are crucial for targeting the prostaglandin-mediated uterine contractions in dysmenorrhea.

Choice D rationale

Nonsteroidal anti-inflammatory drugs (NSAIDs) are considered the optimal pharmacologic therapy for primary dysmenorrhea because they effectively inhibit the production of prostaglandins. Prostaglandins are potent uterine smooth muscle stimulants and vasoconstrictors, directly causing the painful uterine contractions and ischemia associated with dysmenorrhea.